Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 4/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19949079 | 1.00 | FFAR1 (0.49) | FFAR1FFAR4NFKB1NFKB2RELA | |
| SCHEMBL29706814 | 1.00 | FFAR1 (0.49) | FFAR1FFAR4NFKB1NFKB2RELA | |
| SCHEMBL19949077 | 1.00 | FFAR1 (0.49) | FFAR1FFAR4NFKB1NFKB2RELA | |
| SCHEMBL19948926 | 1.00 | FFAR1 (0.49) | FFAR1FFAR4NFKB1NFKB2RELA | |
| SCHEMBL29706810 | 0.91 | EPHX2 (0.44) | NFKB1NFKB2RELAFAAHEPHX2 | |
| SCHEMBL19949347 | 0.91 | EPHX2 (0.44) | NFKB1NFKB2RELAFAAHEPHX2 | |
| SCHEMBL19949378 | 0.91 | EPHX2 (0.44) | FFAR1FFAR4FAAHEPHX2CNR1 | |
| SCHEMBL19949350 | 0.91 | EPHX2 (0.44) | NFKB1NFKB2RELAFAAHEPHX2 | |
| SCHEMBL29706815 | 0.91 | EPHX2 (0.44) | FFAR1FFAR4FAAHEPHX2CNR1 | |
| SCHEMBL19949379 | 0.91 | EPHX2 (0.44) | FFAR1FFAR4FAAHEPHX2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243143-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | AGAIN BIO APS (DK) | 2025-07-31 | — | — | US | disclosed |
| US-12304883-B2 | 1,3-fatty diol compounds and derivatives thereof | GENOMATICA, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4223765-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | Genomatica, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-3795576-B1 | 1,3-FATTY DIOL COMPOUNDS AND GLYCOSYLATED DERIVATIVES THEREOF | GENOMATICA INC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20220098133-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | AGAIN BIO APS (DK) | 2022-03-31 | — | — | US | disclosed |
| US-11168046-B2 | 1,3-fatty diol compounds and derivatives thereof | GENOMATICA, INC. (US) | 2021-11-09 | — | — | US | disclosed |
| US-11168046-B2 | 1,3-fatty diol compounds and derivatives thereof | GENOMATICA, INC. (US) | 2021-11-09 | — | — | US | disclosed |
| EP-3795576-A1 | 1,3-FATTY DIOL COMPOUNDS AND GLYCOSYLATED DERIVATIVES THEREOF | Genomatica, Inc. (US) | 2021-03-24 | — | — | EP | disclosed |
| US-20200385325-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | GENOMATICA, INC. (US) | 2020-12-10 | — | — | US | disclosed |
| US-20200385325-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | GENOMATICA, INC. (US) | 2020-12-10 | — | — | US | disclosed |
| EP-3512825-B1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | GENOMATICA INC (US) | 2020-10-21 | — | — | EP | disclosed |
| US-10570074-B2 | 1,3-fatty diol compounds and derivatives thereof | GENOMATICA, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-10570074-B2 | 1,3-fatty diol compounds and derivatives thereof | GENOMATICA, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| EP-3512825-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG Life Sciences, LLC (US) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018053202-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-22 | — | — | WO | disclosed |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-15 | — | — | US | disclosed |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-15 | — | — | US | disclosed |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570074-B2 | 1,3-fatty diol compounds and derivatives thereof | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
| US-20250243143-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
| US-12304883-B2 | 1,3-fatty diol compounds and derivatives thereof | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
| US-11168046-B2 | 1,3-fatty diol compounds and derivatives thereof | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
| US-20200385325-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
| US-20220098133-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | DGAT1, DGAT2, DSG1 | FFAR1 115/4885FFAR4 287/4885NFKB1 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.